Skip to main content

MARSHALL WACE, LLP

Position in DXCM — Dexcom Inc

CIK 1318757 LONDON, X0

Position in DXCM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$35,884,349
+$31,600,511 QoQ
Shares Held
532,804
+681.1% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#107
of 951 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Jun 30, 2026
CallValue
$53,880
CallShares
800
PutValue
$53,880
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. DXCM ranks #4 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 DXCM
Dexcom Inc
This page
532,804 $35,884,349

All Filings in DXCM

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,884,349 532,804
2026-06-30 $53,880 800
2026-06-30 $53,880 800
2026-03-31 $4,283,838 68,214
2026-03-31 $131,880 2,100
2026-03-31 $106,760 1,700
2025-12-31 $1,095,105 16,500
2025-12-31 $12,748,282 192,079
2025-12-31 $66,370 1,000
2025-09-30 $115,019,805 1,709,315
2025-06-30 $333,629,797 3,822,085
2025-03-31 $72,358,785 1,059,581
2024-12-31 $41,940,972 539,295
2024-09-30 $17,698,560 264,000
2024-06-30 $39,830,960 351,305
2024-03-31 $36,616,800 264,000
2023-12-31 $89,393,566 720,393
2023-09-30 $111,102,012 1,190,804
2023-06-30 $210,832,734 1,640,594
2023-03-31 $343,479,547 2,956,443
2022-12-31 $110,958,892 979,856
2022-09-30 $3,297,871 40,947
2022-06-30 $8,908,198 119,525
2021-12-31 $28,629,099 53,318
2021-03-31 $6,778,814 18,862
2020-12-31 $742,397 2,008
2020-03-31 $163,985 609